RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.

Pancreatic cancer is an aggressive malignancy with characteristic metastatic course of disease and resistance to conventional chemo-radiotherapy. RLIP76 is a multi-functional cell membrane protein that functions as a major mercapturic acid pathway transporter as well as key regulator of receptor-lig...

Full description

Bibliographic Details
Main Authors: Kathryn Leake, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, Sanjay Awasthi, Sharad S Singhal
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3317991?pdf=render
_version_ 1818941333538078720
author Kathryn Leake
Jyotsana Singhal
Lokesh Dalasanur Nagaprashantha
Sanjay Awasthi
Sharad S Singhal
author_facet Kathryn Leake
Jyotsana Singhal
Lokesh Dalasanur Nagaprashantha
Sanjay Awasthi
Sharad S Singhal
author_sort Kathryn Leake
collection DOAJ
description Pancreatic cancer is an aggressive malignancy with characteristic metastatic course of disease and resistance to conventional chemo-radiotherapy. RLIP76 is a multi-functional cell membrane protein that functions as a major mercapturic acid pathway transporter as well as key regulator of receptor-ligand complexes. In this regard, we investigated the significance of targeting RLIP76 on PI3K/Akt pathway and mechanisms regulating response to chemo-radiotherapy.Cell survival was assessed by MTT and colony forming assays. Cellular levels of proteins and phosphorylation was determined by Western blot analyses. The impact on apoptosis was determined by TUNEL assay. The anti-cancer effects of RLIP76 targeted interventions in vivo were determined using mice xenograft model of the pancreatic cancer. The regulation of doxorubicin transport and radiation sensitivity were determined by transport studies and colony forming assays, respectively.Our current studies reveal an encompassing model for the role of RLIP76 in regulating the levels of fundamental proteins like PI3K, Akt, E-cadherin, CDK4, Bcl2 and PCNA which are of specific importance in the signal transduction from critical upstream signaling cascades that determine the proliferation, apoptosis and differentiation of pancreatic cancer cells. RLIP76 depletion also caused marked and sustained regression of established human BxPC-3 pancreatic cancer tumors in nude mouse xenograft model. RLIP76 turned out to be a major regulator of drug transport along with contributing to the radiation resistance in pancreatic cancer.RLIP76 represents a mechanistically significant target for developing effective interventions in aggressive and refractory pancreatic cancers.
first_indexed 2024-12-20T06:53:52Z
format Article
id doaj.art-b4a68b05462342d299f9d248ede6779a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T06:53:52Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b4a68b05462342d299f9d248ede6779a2022-12-21T19:49:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0174e3458210.1371/journal.pone.0034582RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.Kathryn LeakeJyotsana SinghalLokesh Dalasanur NagaprashanthaSanjay AwasthiSharad S SinghalPancreatic cancer is an aggressive malignancy with characteristic metastatic course of disease and resistance to conventional chemo-radiotherapy. RLIP76 is a multi-functional cell membrane protein that functions as a major mercapturic acid pathway transporter as well as key regulator of receptor-ligand complexes. In this regard, we investigated the significance of targeting RLIP76 on PI3K/Akt pathway and mechanisms regulating response to chemo-radiotherapy.Cell survival was assessed by MTT and colony forming assays. Cellular levels of proteins and phosphorylation was determined by Western blot analyses. The impact on apoptosis was determined by TUNEL assay. The anti-cancer effects of RLIP76 targeted interventions in vivo were determined using mice xenograft model of the pancreatic cancer. The regulation of doxorubicin transport and radiation sensitivity were determined by transport studies and colony forming assays, respectively.Our current studies reveal an encompassing model for the role of RLIP76 in regulating the levels of fundamental proteins like PI3K, Akt, E-cadherin, CDK4, Bcl2 and PCNA which are of specific importance in the signal transduction from critical upstream signaling cascades that determine the proliferation, apoptosis and differentiation of pancreatic cancer cells. RLIP76 depletion also caused marked and sustained regression of established human BxPC-3 pancreatic cancer tumors in nude mouse xenograft model. RLIP76 turned out to be a major regulator of drug transport along with contributing to the radiation resistance in pancreatic cancer.RLIP76 represents a mechanistically significant target for developing effective interventions in aggressive and refractory pancreatic cancers.http://europepmc.org/articles/PMC3317991?pdf=render
spellingShingle Kathryn Leake
Jyotsana Singhal
Lokesh Dalasanur Nagaprashantha
Sanjay Awasthi
Sharad S Singhal
RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
PLoS ONE
title RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
title_full RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
title_fullStr RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
title_full_unstemmed RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
title_short RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
title_sort rlip76 regulates pi3k akt signaling and chemo radiotherapy resistance in pancreatic cancer
url http://europepmc.org/articles/PMC3317991?pdf=render
work_keys_str_mv AT kathrynleake rlip76regulatespi3kaktsignalingandchemoradiotherapyresistanceinpancreaticcancer
AT jyotsanasinghal rlip76regulatespi3kaktsignalingandchemoradiotherapyresistanceinpancreaticcancer
AT lokeshdalasanurnagaprashantha rlip76regulatespi3kaktsignalingandchemoradiotherapyresistanceinpancreaticcancer
AT sanjayawasthi rlip76regulatespi3kaktsignalingandchemoradiotherapyresistanceinpancreaticcancer
AT sharadssinghal rlip76regulatespi3kaktsignalingandchemoradiotherapyresistanceinpancreaticcancer